QTc duration is associated with levels of insulin and glucose tolerance: The Zutphen elderly study

Diabetes

Volumn 45, Issue 3, 1996, Pages 376-380

  Dekker, Jacqueline M ^a   Feskens, Edith J M ^b   Schouten, Evert G ^a   Klootwijk, Peter ^c   Pool, Jan ^c   Kromhout, Daan ^b  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; AUTONOMIC DYSFUNCTION; CORONARY RISK; DIABETES MELLITUS; DIABETIC NEUROPATHY; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HEART INNERVATION; HEART MUSCLE METABOLISM; HUMAN; INSULIN BLOOD LEVEL; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QT INTERVAL; SUDDEN DEATH; BLOOD; CORONARY ARTERY DISEASE; DIET RESTRICTION; ELECTROCARDIOGRAPHY; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; METABOLISM; NETHERLANDS; RISK FACTOR;

C PEPTIDE; INSULIN;

AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; C-PEPTIDE; CORONARY DISEASE; ELECTROCARDIOGRAPHY; FASTING; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; MALE; NETHERLANDS; RISK FACTORS;

EID: 0029664327     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.45.3.376     Document Type: Article

References (37)

1. Jervell A, Lange-Nielsen F: Congenital deaf mutism: functional heart disease with prolongation of the QT interval, and sudden death Am Heart J 54:59-68, 1957
2. Peters RW, Byington RP, Barker A, Yusuf S, BHAT Study Group: Prognostic value of prolonged ventricular repolarization following myocardial infarction: the BHAT experience. J Clin Epidemiol 43:167-172, 1990
3. c prolongation measured by standard 12-lead electrocardiography is an independent risk factor for sudden death due to cardiac arrest. Circulation 83:1888-1894, 1991
4. Schouten EG, Dekker JM, Meppelink P, Kok FJ, Vandenbroucke JP, Pool J: QT-interval prolongation predicts cardiovascular mortality in an apparently healthy population. Circulation 84:1516-1523, 1991
5. Dekker JM, Schouten EG, Kromhout D, Pool J: QTc prolongation predicts coronary heart disease in middle-aged and elderly men: the Zutphen Study. Circulation 90:779-785, 1994
6. Schwartz PJ, Priori SG: Sympathetic nervous system and cardiac arrhythmias. In Cardiac Electrophysiology: From Cell to Bed-side. Zipes DP, Jalife J, Eds. Philadelphia, Saunders, 1990, p. 330-343
7. Ben-David J, Zipes DP: Differential response to right and left ansae subclaviae stimulation of early after depolarizations and ventricular tachycardia induced by cesium in dogs. Circulation 78:1241-1250, 1988
8. Zipes DP: The long QT syndrome: a Rosetta stone for sympathetic related ventricular tachyarrhythmias. Circulation 84:1414-1419, 1992
9. Rowe JW, Young JB, Minaker KL, Stevens AL, Pallotta J, Landsberg L: Effect of insulin and glucose infusions on sympathetic nervous system activity in normal men. Diabetes 30:219-225, 1981
10. Vollenweider P, Tappy L, Randin D, Schneiter P, Jéquir E, Nicod P, Scherrer U: Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans. J Clin Invest 92:147-154, 1993
11. Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL: Hyperinsulinemia produces both sympathetic neural activation and vasodilatation in normal humans. J Clin Invest 87:2246-2252, 1991
12. DeFronzo RA, Ferrannini E: Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease Diabetes Care 14:173-194, 1991
13. Keys A, Aravanis C, Blackburn H, van Buchem FSP, Buzina R, Djordevic BS, Dontas AS, Fidanza F, Karvonen MJ, Kimura N, Lekos D, Mondi M, Puddu V, Taylor HL: Epidemiological studies related to coronary heart disease: characteristics of men aged 40-59 in seven countries. Acta Med Scand (Suppl):1-392, 1967
14. Conin JM, Kadroske MM, Schmaltz S, Bastyr EJ, Vinik AI: Corrected QT interval prolongation as diagnostic tool for assessment of cardiac autonomic neuropathy in diabetes mellitus. Diabetes Care 13:68-71, 1990
15. Bellavere F, Ferri M, Guarini L, Bax G, Piccoli A, Cardone C, Fedele D: Prolonged QT period in diabetic autonomic neuropathy a possible role in sudden cardiac death? Br Heart J 59:379-383, 1988
16. Blackburn H, Keys A, Simonson E, Rautaharju P, Punsar S: The electrocardiogram in population studies: a classification system. Circulation 21:1160-1175, 1960
17. World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Org., 1985 (Tech. Rep. Ser., no. 727)
18. Nollo G, Speranza G, Grasso G, Bonamini R, Mangiardi L, Antolini R Spontaneous beat-to-beat variability of the ventricular repolarization duration. J Electrocardiol 25:9-17, 1992
19. Vincent GM, Timothy KW, Leppert M, Keating M: The spectrum of symptoms and QT intervals in carriers of the gene for the long-QT syndrome. N Engl J Med 327:846-852, 1992
20. Siedel J, Schlumberger H, Klose S, Ziegenhorn J, Wahlefeld AW Improved reagent for the enzymatic determination of serum cholesterol. J Clin Chem Clin Biochem 19:1838-1839, 1981
21. 2- precipitation procedure for qualification of high-density-lipoprotein cholesterol. Clin Chem 28:1379-1388, 1982
22. Sullivan DR, Kruijswijk Z, West CE, Kohlmeier M, Katan MB: Determination of serum triglycerides by an enzymatic method not affected by free glycerol. Clin Chem 31:1227-1228, 1985
23. Caspersen CJ, Bloemberg BMP, Saris WHM, Merritt RK, Kromhout D: The prevalence of selected physical activities and their relation with coronary heart disease risk factors in elderly men: the Zutphen Study, 1980. Am J Epidemiol 133.1078-1092, 1991
24. Bazett HC: An analysis of the time relations of electrocardiograms. Heart 7:353-370, 1920
25. SAS: SAS/STAT User's Guide. Release 6.03. 4th ed. Cary, NC, SAS Institute, 1990
26. Campbell Cowan J, Yusoff K, Moore M, Amos PA, Gold AE, Bourke JP, Tansuphaswadikul S, Campbell RWF: Importance of lead selection in QT interval measurement. Am J Cardiol 61:83-87, 1988
27. Scherrer U, Randin D, Tappy L, Vollenweider P, Jéquier E, Nicod P: Body fat and sympathetic nerve activity in healthy subjects. Circulation 89:2634-2640, 1994
28. Andersson B, Elam M, Wallin BG, Bjorntorp P, Andersson OK: Effect of energy restricted diet on sympathetic muscle nerve activity in obese women. Hypertension 18:783-789, 1991
29. Troisi RJ, Weiss ST, Parker DR, Sparrow D, Young JB, Landsberg L. Relation of obesity and diet to sympathetic nervous system activity. Hypertension 17:669-677, 1991
30. Laakso M: How good a marker is insulin level for insulin resistance? Am J Epidemiol 137:959-965, 1993
31. Bekheit S, Isber N, Jani H, Butrous G, Boutjdr M, El-Sherif N: Reduction of ischemia-induced electrophysiologic abnormalities by glucose-insulin infusion. Am Coll Cardiol 22:1214-1222, 1993
32. Almira EC, Garcia AR, Boshell BR: Insulin binding and glucose transport activity in cardiomyocytes of a diabetic rat. Am J Physiol 250:E402-E406, 1986
33. Bravenboer B, Hendriksen PH, Oey LP, Gipsen WH, van Huffelen AC, Erkelens DW: Is the corrected QT interval a reliable indicator of the severity of diabetic autonomie neuropathy? Diabetes Care 16:1249-1253, 1993
34. Lo SS, St. John Sutton M, Leslie RDG: Information in type 1 diabetes mellitus and QT interval from identical twins. Am Heart J 72:305-309, 1993
35. Kleinman JC, Donahue RP, Harris MI, Finucane FF, Madans JH, Brock DB: Mortality among diabetics in a national sample. Am J Epidemiol 128:389-401, 1988
36. Feskens EJM, Kromhout D: Glucose tolerance and the risk of cardiovascular diseases: the Zutphen Study. J Clin Epidemiol 45:1327-1334, 1992
37. Abbott RD, Donahue RP, Kannel WB, Wilson PWF: The impact of diabetes on survival following myocardial infarction in men vs women: the Framingham Study. JAMA 260:3456-3460, 1988